Max Jaderberg and Sergei Yakneen from Isomorphic Labs discuss AI in drug discovery, focusing on deep learning advancements, evolving AI models for drug design, input granularity in NLP and biology data, overlaps in material science and biology, the role of diverse datasets in AI-driven drug discovery, and machine learning applications in neuroscience.